Research & Development
-
Opinion
A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking
Healthcare pros share the market drivers they believe are having the biggest impact on the industry.
By Taren Grom • June 2, 2023 -
Podcast
Woman of the Week: Mirati Therapeutics’ Laurie Stelzer
With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial organization.
By Taren Grom • May 31, 2023 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineCell and gene therapies
How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.
By PharmaVoice staff -
CVS is exiting clinical trials. Does this spell trouble for retail-based research?
Walgreens leaders are not deterred and hope to fill the holes left behind by the pharmacy giant.
By Kelly Bilodeau • May 30, 2023 -
Podcast
Woman of the Week: Cognition Therapeutics’ Lisa Ricciardi
As CEO of the neurogenerative company, Ricciardi is applying her decades of “human capital” to advance Alzheimer’s and dementia treatments.
By Taren Grom • May 24, 2023 -
The cell ‘atlasing’ approach pushing the limits of drug discovery
Vizgen’s CEO discusses the potential of spatial genomics in the life sciences and the company’s role in the movement.
By Taren Grom • May 24, 2023 -
The power of genetics — how research into gene sequencing could revolutionize biopharma
Ancient DNA from a deer tooth. A new way to connect genes with disease. Biological super-computing. These genetic advances could play a part in our biopharma future.
By Michael Gibney • May 23, 2023 -
Biotechs blast experiments into space
Conducting life sciences research in space’s microgravity could have far-ranging implications for drug development on Earth.
By Alexandra Pecci • May 23, 2023 -
Amid surging Duchenne market, Capricor touts potential ‘backbone’ therapy of the space
The company's CEO on the vital role its late-stage candidate could play in the lives of DMD patients.
By Kelly Bilodeau • May 22, 2023 -
(2021). Retrieved from NCI.Making Moves
Biden’s pick to lead the NIH faces an uphill battle
Pending Senate confirmation, NCI head Monica Bertagnolli will take the helm of the collection of research organizations as it faces increasing bipartisan scrutiny.
By Karissa Waddick • May 18, 2023 -
Opinion
What pharma can teach biotech about the life cycle management of a drug
Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.
By Dr. Stephen Dale and Kathleen Ford • May 18, 2023 -
Profile
A day in the life of a pharma exec: Lyndra’s Patricia Hurter
How the CEO starts each day with a ride on one of her horses, reduces daily meetings and uses her network to get through crises like the SVB Bank collapse.
By Meagan Parrish • May 17, 2023 -
Q&A
From farm to pharma: How cows could play a role in the next flu breakthrough
SAb Biotherapeutics is working on a novel product that uses cow antibodies genetically engineered into human antibodies to prevent and treat infectious diseases.
By Alexandra Pecci • May 16, 2023 -
Years into the pandemic, only a handful of clinical trials are targeting long COVID — here’s one of them
Scientists at Stanford are testing Pfizer’s Paxlovid on long COVID symptoms and their efforts could provide clues for other conditions.
By Kelly Bilodeau • May 15, 2023 -
How pharma’s rocky real estate market has changed — for better and worse
Whether you’re looking to build a new site or expand lab space, here are the biggest trends impacting life sciences real estate.
By Karissa Waddick • May 11, 2023 -
Podcast
Woman of the Week: Reneo Pharmaceuticals’ Ashley Hall
After ushering a blockbuster to market, the chief development officer is channeling her experience into the rare disease space.
By Taren Grom • May 10, 2023 -
Q&A
AbbVie’s Christopher Boone on RWE’s potential — and its ‘profound ethical dilemmas’
With decades of experience in public health, Boone is leveraging RWE to move the needle within clinical development.
By Taren Grom • May 10, 2023 -
Profile
This ‘hot-blooded’ CEO is aiming to transform the way burn victims heal
Cutiss CEO Daniela Marino is funneling her bold personality and expertise in regenerative medicine into a startup developing bioengineered skin grafts.
By Alexandra Pecci • May 9, 2023 -
Q&A // Biotech Spotlight
How Immunocore’s Bahija Jallal embraced the ‘a-ha’ moment of promising science
The biotech CEO is bullish on the company’s pioneering T cell receptor platform and innovating new immunology-based treatments.
By Taren Grom • May 5, 2023 -
Podcast
Woman of the Week: Jazz Pharmaceuticals’ Neena Patil
Patil’s dual interests in healthcare and law are at the intersection of her C-suite role.
By Taren Grom • May 3, 2023 -
Biotech Spotlight
Emalex aims at a first-in-class breakthrough for Tourette syndrome
With its phase 3 candidate, the biotech believes it can move the field beyond antipsychotics to a more effective approach.
By Kelly Bilodeau • May 1, 2023 -
Q&A
A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient
The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.
By Taren Grom • May 1, 2023 -
Q&A
5 minutes with — DTRA’s Dr. Amir Kalali
An industry veteran, innovator and curator, Dr. Amir Kalali discusses the high points of his career and his go-to productivity hack.
By Taren Grom • April 28, 2023 -
Scientists could finally be closing in on a ‘pill’ for men
Drug developers have tried — and failed — to create a male contraceptive for decades. Now, one group of scientists might be on the verge of success.
By Kelly Bilodeau • April 26, 2023 -
Tuberculosis is the world’s deadliest infectious disease — and treatments remain underfunded
Tuberculosis control and funding lost 20 years of progress during the COVID-19 pandemic, but scientists and world health groups are still plugging away.
By Alexandra Pecci • April 24, 2023 -
20 years on, the next stage of the human genome revolution is brewing
Two decades after the Human Genome Project, scientists are on the brink of uncovering its full potential for drug development.
By Karissa Waddick • April 24, 2023